Genesis Therapeutics: valuation, funding, and the secondary tape

Layer: Apps & vertical SaaS company site

The short version

instrumentvalueas ofsource
Claimed valuationn/agraph
Open roles (tracked board)5source

747 Clarity prints, 2024-10-07 to 2026-10-18

Funding rounds on record

dateamountpost-moneysource
2026-05-01$40.00Mn/asource
2023-08-25$224.03Mn/asource
2022-12-23$23.89Mn/asource
2020-12-09$49.52Mn/asource

All filed/seeded rounds in the graph, newest first; same-month same-amount prints collapse to one line.

Related companies

Recent milestones

marks table | napkin table | the scorecard | all companies

Derived from the SOMEN graph at render time.